Smith & Nephew plc SN.L Stock
Smith & Nephew plc Price Chart
Smith & Nephew plc SN.L Financial and Trading Overview
Smith & Nephew plc stock price | 961.2 GBP |
Previous Close | 1251 GBP |
Open | 1252.5 GBP |
Bid | 1259 GBP x 0 |
Ask | 1260 GBP x 0 |
Day's Range | 1250.5 - 1261.5 GBP |
52 Week Range | 959.2 - 1316.75 GBP |
Volume | 149.41K GBP |
Avg. Volume | 3.04M GBP |
Market Cap | 11B GBP |
Beta (5Y Monthly) | 0.389272 |
PE Ratio (TTM) | 59.976192 |
EPS (TTM) | 0.24 GBP |
Forward Dividend & Yield | 0.31 (2.63%) |
Ex-Dividend Date | March 30, 2023 |
1y Target Est | 13.72 GBP |
SN.L Valuation Measures
Enterprise Value | 13.39B GBP |
Trailing P/E | 59.976192 |
Forward P/E | 15.943037 |
PEG Ratio (5 yr expected) | 2.76 |
Price/Sales (ttm) | 2.1093423 |
Price/Book (mrq) | 208.38847 |
Enterprise Value/Revenue | 2.568 |
Enterprise Value/EBITDA | 12.02 |
Trading Information
Smith & Nephew plc Stock Price History
Beta (5Y Monthly) | 0.389272 |
52-Week Change | 9.32% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1316.75 GBP |
52 Week Low | 959.2 GBP |
50-Day Moving Average | 1233.39 GBP |
200-Day Moving Average | 1134.82 GBP |
SN.L Share Statistics
Avg. Volume (3 month) | 3.04M GBP |
Avg. Daily Volume (10-Days) | 2.67M GBP |
Shares Outstanding | 873.38M |
Float | 860.11M |
Short Ratio | N/A |
% Held by Insiders | 0.19% |
% Held by Institutions | 56.33% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.375 |
Trailing Annual Dividend Yield | 0.029% |
5 Year Average Dividend Yield | 208.00% |
Payout Ratio | 1.5132 |
Last Split Factor | 9:11 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 4.27% |
Operating Margin (ttm) | 12.75% |
Gross Margin | 70.85% |
EBITDA Margin | 21.36% |
Management Effectiveness
Return on Assets (ttm) | 3.98% |
Return on Equity (ttm) | 4.11% |
Income Statement
Revenue (ttm) | 5.22B GBP |
Revenue Per Share (ttm) | 5.98 GBP |
Quarterly Revenue Growth (yoy) | 0.10% |
Gross Profit (ttm) | 3.7B GBP |
EBITDA | 1.11B GBP |
Net Income Avi to Common (ttm) | 223M GBP |
Diluted EPS (ttm) | 0.21 |
Quarterly Earnings Growth (yoy) | -85.59% |
Balance Sheet
Total Cash (mrq) | 350M GBP |
Total Cash Per Share (mrq) | 0.4 GBP |
Total Debt (mrq) | 2.87B GBP |
Total Debt/Equity (mrq) | 54.61 GBP |
Current Ratio (mrq) | 2.248 |
Book Value Per Share (mrq) | 6.044 |
Cash Flow Statement
Operating Cash Flow (ttm) | 468M GBP |
Levered Free Cash Flow (ttm) | 138.62M GBP |
Profile of Smith & Nephew plc
Country | United Kingdom |
State | N/A |
City | Watford |
Address | Building 5 |
ZIP | WD18 8YE |
Phone | 44 1923 477 100 |
Website | https://www.smith-nephew.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 19012 |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Q&A For Smith & Nephew plc Stock
What is a current SN.L stock price?
Smith & Nephew plc SN.L stock price today per share is 961.2 GBP.
How to purchase Smith & Nephew plc stock?
You can buy SN.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Smith & Nephew plc?
The stock symbol or ticker of Smith & Nephew plc is SN.L.
Which industry does the Smith & Nephew plc company belong to?
The Smith & Nephew plc industry is Medical Devices.
How many shares does Smith & Nephew plc have in circulation?
The max supply of Smith & Nephew plc shares is 8.74M.
What is Smith & Nephew plc Price to Earnings Ratio (PE Ratio)?
Smith & Nephew plc PE Ratio is 40.05000300 now.
What was Smith & Nephew plc earnings per share over the trailing 12 months (TTM)?
Smith & Nephew plc EPS is 0.24 GBP over the trailing 12 months.
Which sector does the Smith & Nephew plc company belong to?
The Smith & Nephew plc sector is Healthcare.
Smith & Nephew plc SN.L included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq CRD Global Sustainabilit NQCRD | 1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
FTSE 350 FTLC | 4398.53 GBP 5625.44 USD |
+0.73
|
— — | 4366.53 GBP 5584.51 USD | 4428.44 GBP 5663.69 USD | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
FTSE 100 FTSE | 7995.58 GBP 10225.83 USD |
+0.91
|
— — | 7923.8 GBP 10134.03 USD | 8044.98 GBP 10289.01 USD | — - | — — |
UK FTSE All Share FTAS | 4353.66 GBP 5568.05 USD |
+0.72
|
— — | 4322.37 GBP 5528.03 USD | 4382.9 GBP 5605.45 USD | — - | — — |
- {{ link.label }} {{link}}